HEALTHCARE REALTY TRUST INC (HR) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HR - US42226K1051 - REIT
18.005 USD
-0.23 (-1.23%)
Overall HR gets a fundamental rating of 3 out of 10. We evaluated HR against 128 industry peers in the Diversified REITs industry. HR has a bad profitability rating. Also its financial health evaluation is rather negative. HR has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year HR has reported negative net income.
In the past year HR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: HR reported negative net income in multiple years.
Each year in the past 5 years HR had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -3.76%, HR is not doing good in the industry: 79.69% of the companies in the same industry are doing better.
The Return On Equity of HR (-7.91%) is worse than 71.09% of its industry peers.
The Return On Invested Capital of HR (0.51%) is worse than 86.72% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HR is below the industry average of 3.06%.
The last Return On Invested Capital (0.51%) for HR is above the 3 year average (0.38%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -7.91% | ||
| ROIC | 0.51% |
ROA(3y)-2.72%
ROA(5y)-1.19%
ROE(3y)-5.41%
ROE(5y)-2.31%
ROIC(3y)0.38%
ROIC(5y)1.07%
1.3 Margins
HR has a Operating Margin of 5.10%. This is amonst the worse of the industry: HR underperforms 85.16% of its industry peers.
HR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 62.40%, HR is doing worse than 62.50% of the companies in the same industry.
In the last couple of years the Gross Margin of HR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.1% | ||
| PM (TTM) | N/A | ||
| GM | 62.4% |
OM growth 3Y-49.95%
OM growth 5Y-33.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y-2.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HR is destroying value.
The number of shares outstanding for HR has been reduced compared to 1 year ago.
Compared to 5 years ago, HR has more shares outstanding
HR has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.22, we must say that HR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.22, HR is not doing good in the industry: 64.84% of the companies in the same industry are doing better.
HR has a debt to FCF ratio of 36.37. This is a negative value and a sign of low solvency as HR would need 36.37 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 36.37, HR is doing good in the industry, outperforming 71.88% of the companies in the same industry.
HR has a Debt/Equity ratio of 0.97. This is a neutral value indicating HR is somewhat dependend on debt financing.
HR's Debt to Equity ratio of 0.97 is fine compared to the rest of the industry. HR outperforms 63.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 36.37 | ||
| Altman-Z | 0.22 |
ROIC/WACC0.08
WACC6.35%
2.3 Liquidity
HR has a Current Ratio of 0.13. This is a bad value and indicates that HR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.13, HR is doing worse than 95.31% of the companies in the same industry.
HR has a Quick Ratio of 0.13. This is a bad value and indicates that HR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.13, HR is not doing good in the industry: 95.31% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.13 | ||
| Quick Ratio | 0.13 |
3. Growth
3.1 Past
The earnings per share for HR have decreased strongly by -15.22% in the last year.
Looking at the last year, HR shows a very negative growth in Revenue. The Revenue has decreased by -25.49% in the last year.
HR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.88% yearly.
EPS 1Y (TTM)-15.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.62%
Revenue 1Y (TTM)-25.49%
Revenue growth 3Y18.25%
Revenue growth 5Y12.88%
Sales Q2Q%-5.6%
3.2 Future
HR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.47% yearly.
HR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.33% yearly.
EPS Next Y52.79%
EPS Next 2Y33.79%
EPS Next 3Y22.47%
EPS Next 5YN/A
Revenue Next Year-6.68%
Revenue Next 2Y-3.72%
Revenue Next 3Y-1.82%
Revenue Next 5Y-1.33%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for HR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HR is valued a bit more expensive than 65.63% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HR is valued a bit cheaper than the industry average as 64.06% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.52 | ||
| EV/EBITDA | 16.6 |
4.3 Compensation for Growth
HR's earnings are expected to grow with 22.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.79%
EPS Next 3Y22.47%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.02%, HR is a good candidate for dividend investing.
HR's Dividend Yield is a higher than the industry average which is at 6.34.
HR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.02% |
5.2 History
The dividend of HR has a limited annual growth rate of 0.57%.
HR has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of HR decreased recently.
Dividend Growth(5Y)0.57%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
HR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of HR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-111.25%
EPS Next 2Y33.79%
EPS Next 3Y22.47%
NYSE:HR (12/1/2025, 3:03:10 PM)
18.005
-0.23 (-1.23%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners111.2%
Inst Owner Change5.71%
Ins Owners0.58%
Ins Owner Change-1%
Market Cap6.33B
Revenue(TTM)1.20B
Net Income(TTM)-370.62M
Analysts74
Price Target19.83 (10.14%)
Short Float %4.69%
Short Ratio4.2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.02% |
Yearly Dividend1.25
Dividend Growth(5Y)0.57%
DP-111.25%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-343.81%
Min EPS beat(2)-446.12%
Max EPS beat(2)-241.5%
EPS beat(4)0
Avg EPS beat(4)-254.5%
Min EPS beat(4)-446.12%
Max EPS beat(4)-40.24%
EPS beat(8)1
Avg EPS beat(8)-216.28%
EPS beat(12)1
Avg EPS beat(12)-161.8%
EPS beat(16)3
Avg EPS beat(16)-58.3%
Revenue beat(2)0
Avg Revenue beat(2)-1.49%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)-1.38%
Revenue beat(4)0
Avg Revenue beat(4)-1.61%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)-1.18%
Revenue beat(8)1
Avg Revenue beat(8)-1.47%
Revenue beat(12)1
Avg Revenue beat(12)-1.38%
Revenue beat(16)2
Avg Revenue beat(16)2.7%
PT rev (1m)8.02%
PT rev (3m)11.57%
EPS NQ rev (1m)94.28%
EPS NQ rev (3m)96.43%
EPS NY rev (1m)0%
EPS NY rev (3m)-64.7%
Revenue NQ rev (1m)0.46%
Revenue NQ rev (3m)-1.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 5.26 | ||
| P/FCF | 50.52 | ||
| P/OCF | 13.68 | ||
| P/B | 1.35 | ||
| P/tB | 1.35 | ||
| EV/EBITDA | 16.6 |
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)0.36
FCFY1.98%
OCF(TTM)1.32
OCFY7.31%
SpS3.42
BVpS13.32
TBVpS13.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -7.91% | ||
| ROCE | 0.64% | ||
| ROIC | 0.51% | ||
| ROICexc | 0.51% | ||
| ROICexgc | 0.54% | ||
| OM | 5.1% | ||
| PM (TTM) | N/A | ||
| GM | 62.4% | ||
| FCFM | 10.41% |
ROA(3y)-2.72%
ROA(5y)-1.19%
ROE(3y)-5.41%
ROE(5y)-2.31%
ROIC(3y)0.38%
ROIC(5y)1.07%
ROICexc(3y)0.38%
ROICexc(5y)1.09%
ROICexgc(3y)0.39%
ROICexgc(5y)1.1%
ROCE(3y)0.48%
ROCE(5y)1.36%
ROICexgc growth 3Y-49.37%
ROICexgc growth 5Y-31.73%
ROICexc growth 3Y-49.34%
ROICexc growth 5Y-31.78%
OM growth 3Y-49.95%
OM growth 5Y-33.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y-2.03%
F-Score5
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 36.37 | ||
| Debt/EBITDA | 6.92 | ||
| Cap/Depr | 56.54% | ||
| Cap/Sales | 28.03% | ||
| Interest Coverage | 0.33 | ||
| Cash Conversion | 70.3% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.13 | ||
| Quick Ratio | 0.13 | ||
| Altman-Z | 0.22 |
F-Score5
WACC6.35%
ROIC/WACC0.08
Cap/Depr(3y)74.85%
Cap/Depr(5y)98.72%
Cap/Sales(3y)37.95%
Cap/Sales(5y)42.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.62%
EPS Next Y52.79%
EPS Next 2Y33.79%
EPS Next 3Y22.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-25.49%
Revenue growth 3Y18.25%
Revenue growth 5Y12.88%
Sales Q2Q%-5.6%
Revenue Next Year-6.68%
Revenue Next 2Y-3.72%
Revenue Next 3Y-1.82%
Revenue Next 5Y-1.33%
EBIT growth 1Y-2.63%
EBIT growth 3Y-40.82%
EBIT growth 5Y-24.46%
EBIT Next Year1179.86%
EBIT Next 3Y135.49%
EBIT Next 5Y91.35%
FCF growth 1Y-26.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.75%
OCF growth 3Y9.16%
OCF growth 5Y8.06%
HEALTHCARE REALTY TRUST INC / HR FAQ
What is the ChartMill fundamental rating of HEALTHCARE REALTY TRUST INC (HR) stock?
ChartMill assigns a fundamental rating of 3 / 10 to HR.
What is the valuation status of HEALTHCARE REALTY TRUST INC (HR) stock?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHCARE REALTY TRUST INC (HR). This can be considered as Overvalued.
Can you provide the profitability details for HEALTHCARE REALTY TRUST INC?
HEALTHCARE REALTY TRUST INC (HR) has a profitability rating of 2 / 10.
What is the financial health of HEALTHCARE REALTY TRUST INC (HR) stock?
The financial health rating of HEALTHCARE REALTY TRUST INC (HR) is 2 / 10.
What is the earnings growth outlook for HEALTHCARE REALTY TRUST INC?
The Earnings per Share (EPS) of HEALTHCARE REALTY TRUST INC (HR) is expected to grow by 52.79% in the next year.